AstraZeneca starts work on Egyptian facility
AstraZeneca has started construction a €30 million tablet manufacturing plant in Egypt that could form a springboard for an expansion into emerging markets.
Archives for December 2, 2004
Biomanufacturing at overcapacity through to 2011
The predicted deficit in manufacturing capacity for biologic drugs that has been tipped to impede the development of the market has not materialised, with capacity exceeding demand, according to new market research.
International production news round-up
In-Pharmatechnologist.com's periodic round-up of pharma production developments from around the world sees Cognis mulling the sale of process chemicals, Perrigo buying a generics and API manufacturer and two new contract manufacturing agreements.
New generation PEG launched
UK company Warwick Effect Polymers has launched a new type of polyethylene glycol (PEG) to improve the half-life of biologic drugs in the body.
Niro unveils lab-based processing system
Niro Pharma Systems recently launched a new laboratory fluid bed - the STREA-1 - for the processing of fine powders, pellets, granules, crystals, tablets and organic solvents. The system, developed by Aeromatic-Fielder, is designed to offer a flexible...